Comparing the projected cost per HbA1c reduction of exenatide QW versus liraglutide 1.8 mg for the treatment of type 2 diabetes mellitus using alternate data sources

Saved in:
Bibliographic Details
Published in:Value in health 2014-05, Vol.17 (3), p.A250-A250
Main Authors: Wang, B, Nguyen, H, Felber, E, Furnback, W, Roth, J, Garrison, L
Format: Article
Language:English
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2014.03.1456